![Thierry Chauche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 160 959 $ in data 31/08/2026
Thierry Chauche is currently Chief Financial & Accounting Officer at Sagimet Biosciences, Inc. since 2024.
Formerly, Mr. Chauche was Chief Financial Officer at Provention Bio, Inc. from 2021 to 2023 and VP, Head-Strategic Financial Planning & Analysis at Alexion Pharmaceuticals, Inc. from 2020 to 2021.
Education includes an MBA from The Wharton School of the University of Pennsylvania and a graduate degree from école Des Ponts Paristec.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/05/2026 | 15.688 ( 0,03% ) | 160 959 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Direttore Finanziario/CFO | 06/05/2024 |
| Società | Posizione | Fine |
|---|---|---|
| PROVENTION BIO, INC. | Direttore Finanziario/CFO | 01/04/2023 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
école Des Ponts Paristec
 école Des Ponts Paristec Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
